HomeReleases

Releases

Global Indocyanine Green Market Projected to Reach $380 Million by 2031

Releases

Global Indocyanine Green Market Projected to Reach $380 Million by 2031

The global indocyanine green market is set for significant expansion, with valuations expected to climb from $180 million in 2025 to $380 million by 2031. Driven by a compound annual growth rate of 13.26%, the sector is benefiting from the rapid integration of fluorescence imaging into modern surgical and diagnostic workflows.

William P. Moon Jr. Honored as 2026 Broker of the Year

Releases

William P. Moon Jr. Honored as 2026 Broker of the Year

After two decades navigating the real estate landscape of Oil City, Pennsylvania, William P. Moon Jr. has been named a 2026 Broker of the Year by The Inner Circle. His recognition highlights a career defined by a technical background in construction and a deep-rooted commitment to local civic leadership.

Money Talk·Jul 22
Where Our Children Play Targets Sports Burnout With Holistic Model

Releases

Where Our Children Play Targets Sports Burnout With Holistic Model

Traditional youth sports often prioritize scoreboards over personal growth, forcing many children to abandon athletics entirely due to burnout. Where Our Children Play is expanding its alternative coaching model to Las Vegas and Italy, offering a curriculum focused on cognitive development and resilience rather than just competitive outcomes.

Money Talk·Jul 22
D2L Lumi Secures Best of Show Award at ISTELive 2026

Releases

D2L Lumi Secures Best of Show Award at ISTELive 2026

At the ISTELive 2026 conference, D2L Lumi earned the Tech & Learning Best of Show award in the higher education category. The platform, integrated directly into D2L Brightspace, was recognized for its ability to balance AI-driven efficiencies with the core human elements of teaching and student support.

Spigen Debuts Hinge-Focused Case Lineup for Galaxy Z Fold 8

Releases

Spigen Debuts Hinge-Focused Case Lineup for Galaxy Z Fold 8

As Samsung unveils its latest foldable generation in London, accessory manufacturer Spigen is responding with a redesigned collection of cases. Leveraging seven years of experience with the Galaxy Z series, the company has introduced specialized hinge protection technology to address the specific vulnerabilities of the new Galaxy Z Fold 8.

Geography Drives High Rates of Unnecessary Knee Surgeries

Releases

Geography Drives High Rates of Unnecessary Knee Surgeries

A patient’s odds of receiving an unproven knee surgery depend largely on their zip code, according to a new analysis of 100 million U.S. insurance claims. Despite clinical trials showing physical therapy is often just as effective, over 500,000 meniscectomies are performed annually at a $4 billion cost.

Transpacific Future Center Opens Permanent D.C. Headquarters

Releases

Transpacific Future Center Opens Permanent D.C. Headquarters

A historic property on Jefferson Place now serves as the permanent home for the Transpacific Future Center, signaling a strategic shift toward long-term policy dialogue. Supported by a 3 million dollar endowment from Evermay, the organization aims to centralize its leadership initiatives within the nation’s capital to strengthen regional ties.

Fundamental Advisors Acquires BlueSky Helicopters to Scale Aerial Fleet

Releases

Fundamental Advisors Acquires BlueSky Helicopters to Scale Aerial Fleet

With five additional aircraft now under its control, New York-based Fundamental Advisors has acquired Southern California operator BlueSky Helicopters. The deal bolsters the investment firm's public service aviation platform, specifically targeting high-demand aerial firefighting and utility infrastructure markets across the Western United States.

CAR T-Cell Therapy Market for Non-Hodgkin Lymphoma Projected to Grow

Releases

CAR T-Cell Therapy Market for Non-Hodgkin Lymphoma Projected to Grow

The global market for CAR T-cell therapy in non-Hodgkin lymphoma is poised for steady expansion, with projections indicating a compound annual growth rate of approximately 7% through 2036. This upward trajectory reflects a broader clinical shift from traditional chemo-immunotherapy toward specialized, cell-based treatment modalities for patients with complex disease profiles.

Releases

AI Drug Discovery Market Forecast to Reach $17.56 Billion by 2031

The global market for artificial intelligence in drug discovery is poised for a significant transformation, with projections indicating a jump from $5.09 billion in 2026 to $17.56 billion by 2031. This expansion represents a steady compound annual growth rate of 28.1% as pharmaceutical firms pivot toward integrated, data-driven R&D environments.

Money Talk·Jul 22
Grail Investors Face August 4 Deadline in Securities Class Action

Releases

Grail Investors Face August 4 Deadline in Securities Class Action

Investors who suffered losses following the failure of Grail, Inc.’s NHS-Galleri clinical trial have until August 4, 2026, to file as lead plaintiffs. The class action centers on allegations that the company misled shareholders regarding the trial's prospects before a significant market collapse in February.

Money Talk·Jul 22
Investors Face August Deadline in ZoomInfo Securities Class Action

Releases

Investors Face August Deadline in ZoomInfo Securities Class Action

Investors who purchased ZoomInfo Technologies, Inc. (NASDAQ: GTM) shares between November 3, 2025, and May 11, 2026, face an August 24 deadline to file for lead plaintiff status. This legal action follows a 33% stock price collapse sparked by the company’s sudden reversal in financial guidance and growth projections.

Money Talk·Jul 22
Microsoft Faces Class Action Lawsuit Over Copilot AI Performance Claims

Releases

Microsoft Faces Class Action Lawsuit Over Copilot AI Performance Claims

Investors who purchased Microsoft Corporation securities between May 1, 2025, and January 28, 2026, are being urged to contact legal counsel following the filing of a class action lawsuit in the U.S. District Court for the Western District of Washington regarding alleged misrepresentations of the company's AI initiatives.

PicS N.V. Faces Class Action Lawsuit Over IPO Credit Disclosures

Releases

PicS N.V. Faces Class Action Lawsuit Over IPO Credit Disclosures

Investors who bought PicS N.V. shares during the company’s January 2026 IPO face a looming August 4 deadline to join a securities class action. The lawsuit alleges that the digital bank concealed significant credit portfolio deficiencies and a massive loan reclassification that occurred just weeks before the company went public.

Money Talk·Jul 22
Triumph Higher Education Group Acquires Culinary Institute of Barcelona

Releases

Triumph Higher Education Group Acquires Culinary Institute of Barcelona

Triumph Higher Education Group has acquired the Culinary Institute of Barcelona, marking a strategic expansion into the European market. The deal integrates the innovative, entrepreneur-focused Spanish school into a portfolio that already includes the Auguste Escoffier School of Culinary Arts and the Pacific Institute of Culinary Arts.

Money Talk·Jul 22
Triumph Higher Education Group Acquires Culinary Institute of Barcelona

Releases

Triumph Higher Education Group Acquires Culinary Institute of Barcelona

Triumph Higher Education Group has expanded its global footprint by acquiring the Culinary Institute of Barcelona, a move that integrates the Spanish school’s innovation-focused methodology into a network already anchored by the Auguste Escoffier School of Culinary Arts and the Pacific Institute of Culinary Arts in Vancouver.

Intuit Faces Class Action Over Alleged TurboTax Misrepresentations

Releases

Intuit Faces Class Action Over Alleged TurboTax Misrepresentations

Investors who purchased Intuit Inc. stock between August 22, 2025, and May 20, 2026, are being urged to contact Levi & Korsinsky, LLP regarding a new class action lawsuit. The litigation centers on claims that the firm misled shareholders about the competitive strength and growth trajectory of its TurboTax business.

Money Talk·Jul 22
Insulet Faces Securities Lawsuit Over Manufacturing and Quality Failures

Releases

Insulet Faces Securities Lawsuit Over Manufacturing and Quality Failures

Insulet Corporation faces a class-action lawsuit as investors seek to recoup losses following a sharp decline in share price. The litigation centers on allegations that the company misled shareholders regarding the manufacturing quality of its Omnipod insulin delivery systems, which were later subject to two major recalls.

Money Talk·Jul 22
Nano-X Imaging Faces Class Action Lawsuit Over Manufacturing Claims

Releases

Nano-X Imaging Faces Class Action Lawsuit Over Manufacturing Claims

A securities class action lawsuit has been filed against Nano-X Imaging Ltd. following a 24.39% stock price collapse on April 20, 2026. Investors allege the company misled shareholders regarding the efficiency and scalability of its Korean chip manufacturing facility, which was ultimately shuttered following significant impairment charges.

Agilisium Joins Anthropic’s Claude Partner Network

Releases

Agilisium Joins Anthropic’s Claude Partner Network

Agilisium has secured Select Services Partner status within the Claude Partner Network, formalizing its role in deploying agentic AI for the life sciences sector. The Los Angeles-based firm is integrating Anthropic’s reasoning models into its proprietary FDX framework to support high-stakes clinical and regulatory environments.

Investors Face Massive Losses Following Alleged Megan Holdings Scheme

Releases

Investors Face Massive Losses Following Alleged Megan Holdings Scheme

A class action lawsuit filed in New York alleges that Megan Holdings Limited operated as a shell company to facilitate a coordinated pump-and-dump scheme. The litigation targets the aquaculture firm’s leadership and underwriters, claiming they misled investors through fabricated operational growth and baseless stock promotion between September 2025 and March 2026.

Money Talk·Jul 22
Peabody Energy Investors Face August Deadline in Centurion Mine Lawsuit

Releases

Peabody Energy Investors Face August Deadline in Centurion Mine Lawsuit

Investors who purchased Peabody Energy stock between October 14, 2024, and May 4, 2026, face an August 24, 2026, deadline to seek lead plaintiff status in a securities class action. The lawsuit targets alleged misrepresentations made by former executive Marc E. Hathhorn regarding the company’s Centurion mine operations.

Brian Grass Named in Helen of Troy Securities Class Action

Releases

Brian Grass Named in Helen of Troy Securities Class Action

Conflict lead: A federal class action lawsuit now targets Brian Grass, the former CFO and interim CEO of Helen of Troy Limited, alleging he misled shareholders regarding the success of the company’s Project Pegasus restructuring program while overseeing the firm’s financial disclosures between April 2024 and October 2025.

Money Talk·Jul 22
GeneDx Faces Securities Lawsuit Following $31.2 Million Impairment Charge

Releases

GeneDx Faces Securities Lawsuit Following $31.2 Million Impairment Charge

Investors who purchased GeneDx Holdings Corp. stock between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to seek lead plaintiff status in a newly filed securities class action. The litigation follows a 49.2% single-day share price collapse triggered by disclosures regarding the firm's Fabric Genomics acquisition.

Money Talk·Jul 22
ADMA Biologics Faces Class Action Over Alleged Revenue Inflation

Releases

ADMA Biologics Faces Class Action Over Alleged Revenue Inflation

Investors in ADMA Biologics, Inc. are facing an August 10, 2026, deadline to join a securities class action lawsuit. The complaint alleges the company used channel stuffing to artificially inflate revenues for its specialty therapy ASCENIV, masking what may have been a 3% decline as 20% growth.

Money Talk·Jul 22
Investors Target Lucid Group Over Alleged Misleading Production Claims

Releases

Investors Target Lucid Group Over Alleged Misleading Production Claims

Lucid Group faces a class action lawsuit following revelations that management touted a repeatable operating cadence while secretly grappling with a month-long delivery halt. Investors claim the company’s February 2026 assurances of structural progress masked a supplier-driven crisis that ultimately triggered a sharp decline in share price.

Money Talk·Jul 22